Hepatitis C virus (HCV) infection is highly prevalent and is associated with substantial morbidity and mortality among persons infected with the human immunodeficiency virus (HIV). We compared the ...

Nov. 1, 2004 (Boston) — In patients with chronic hepatitis B virus (HBV) infection positive for the HBe antigen, monotherapy with peginterferon alfa-2a (40 KD) produces significantly higher response ...

March 30, 2012 (New York, New York) — Peginterferon alfa-2a, in combination with the protease inhibitor boceprevir and ribavirin (R), was shown to have efficacy equivalent or superior to that seen ...

Chronic hepatitis C virus (HCV) infection is a cause of major complications in persons who are also infected with the human immunodeficiency virus (HIV). However, the treatment of HCV infection in ...

Diagnostic Performance of Whole Body Dual Modality 18F-FDG PET/CT Imaging for N- and M-Staging of Malignant Melanoma: Experience With 250 Consecutive Patients PEG-IFNα-2a was administered ...

The combination with 10mg bulevirtide dose helps more patients achieve undetectable hepatitis D virus than bulevirtide alone. HealthDay News — The combination of bulevirtide plus peginterferon alfa-2a ...

Weekly peginterferon alfa-2a therapy, with or without daily adefovir, cleared hepatitis D virus (HDV) RNA in about one quarter of patients who participated in the Hep-Net-International Delta Hepatitis ...

Background. With use of peginterferon alfa-2a and ribavirin combination therapy in patients with dual chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infection, 11.2% of patients achieved ...

Peginterferon alfa-2a (Pegasys, Roche) has UK marketing authorisation for the treatment of HBeAg-positive or HBeAg-negative chronic hepatitis B in adults with compensated liver disease and evidence of ...

An audit could be carried out to ensure that adefovir dipivoxil and peginterferon alfa-2a are being used appropriately for the treatment of people with chronic hepatitis B. An audit could be carried ...